Concert Pharmaceuticals Inc. buy Lokrim
Start price
28.05.22
/
20%
€5.40
Target price
28.05.23
-
Performance (%)
46.05%
End price
24.04.23
€7.88
Summary
This prediction ended on 24.04.23 with a price of €7.88. With a performance of 46.05% the BUY prediction by Lokrim was a big success. Lokrim has 20% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Concert Pharmaceuticals Inc. | - | - | - |
iShares Core DAX® | 2.149% | 5.415% | 21.385% |
iShares Nasdaq 100 | 0.838% | 1.926% | 44.386% |
iShares Nikkei 225® | 1.143% | 2.887% | 27.641% |
iShares S&P 500 | 1.265% | 3.698% | 33.327% |
According to Lokrim what are the pros and cons of Concert Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Lokrim for this prediction
In the thread Concert Pharmaceuticals Inc. diskutieren
Buy Concert Pharmaceuticals Inc.
In the thread Trading Concert Pharmaceuticals Inc.
Buy beendet
Stopped prediction by Lokrim for Concert Pharmaceuticals Inc.
Concert Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.44
17.10.21
17.10.21
-
17.10.22
17.10.22
121.23%
28.05.22
28.05.22
Could be worthwhile Investment >10% per year